Note: Ingredients listed on restricted chemical lists
EC/CAS
216-455-5/1589-47-5
Name of the chemical
2-methoxypropanol
Concentration
<0,15%
General Information
Version
1.0/EN
Revision date
2023-02-03
Product name
WOOD - LEMON
Manufacturer Name
Dr. MARCUS International Sp. z o.o.
Icons in SDS
Company Information
company name
Dr. MARCUS International Sp. z o.o.
e-mail address of the competent person responsible for the Safety Data Sheet
drmarcus@dr-marcus.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H226, H317, H336, H412
Hazard statements
Code
Statements
H226
Flammable liquid and vapour
Section 2
2.1 Classification of the substance or mixture
Flam. Liq. 3 H226, Skin Sens. 1 H317, STOT SE 3 H336, Aquatic Chronic 3 H412 Flammable liquid and vapour. May cause an allergic skin reaction. May cause drowsiness or dizziness. Harmful to aquatic life with long lasting effects.
2.2 Label elements
Hazard pictograms and signal words Warning Hazardous components placed on the label
Contains
1-methoxy-2-propanol; citronellal; 3-methyl-5-phenylpent-2-enenitrile; cineole; 4-(4-methyl-3- pentenyl)cyclohex-3-ene-1-carbaldehyde.
Hazard statements
H226 Flammable liquid and vapour. H317 May cause an allergic skin reaction. H336 May cause drowsiness or dizziness. H412 Harmful to aquatic life with long lasting effects.
Precautionary statements
P101 If medical advice is needed, have product container or label at hand. P102 Keep out of reach of children. P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P273 Avoid release to the environment. P333+P313 If skin irritation or rash occurs: Get medical advice/attention. P501 Dispose of contents/container to properly labelled waste containers according to national law.
Additional information
None
2.3 Other hazards
Product does not contain components, which meet criteria for PBT or vPvB in accordance with Annex XIII of REACH Regulation. The product does not contain substances included in the list established in accordance with Article 59(1) for having endocrine disrupting properties, or substances identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 (3) or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % by weight.
